» Dr. Gennady Verkhivker

Schmid College of Science and Technology; Physics, Computational Science and Engineering
Dr. Gennady Verkhivker
Office Location:
Hashinger Science Center 118
Lomonosov Moscow State University, Bachelor of Science
Lomonosov Moscow State University, Master of Science
Dr. Verkhivker is currently a Professor of Computational Biology. He is also an Adjunct Professor of Pharmacology at the Department of Pharmacology, UC San Diego. His research activities are in the areas of computational cancer biology, translational bioinformatics, and computational pharmacology. He received his PhD in Physical Chemistry from Moscow University and completed a postdoctoral fellowship in computational biophysics from University of Illinois at Chicago. In 2000-2005, Dr. Verkhivker has held various research and management positions at Pfizer Global Research and Development, San Diego.  Since 2002, he has been Adjunct Professor of Pharmacology at the Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego. In 2006, he joined School of Pharmacy and Center for Bioinformatics, The University of Kansas as a Professor of Pharmaceutical Chemistry and Bioinformatics. Dr. Verkhivker returned to California in 2011 and joined Chapman University in August 2011 as a Full Professor of Computational Biology. Upon arrival to Chapman, Dr. Verkhivker has established a dynamic research group engaged in translational research that attracted a large cohort of undergraduate and graduate students.  He has been involved in various global University initiatives and collaborations. Dr. Verkhivker has served on a number of important committees including Search Committee for new Found Dean of BioPharmacy School. He is also chairing the Doctoral Steering Committee of the newly approved PhD Graduate Program in Computational Sciences.
Recent Creative, Scholarly Work and Publications
Allosteric regulation of the Hsp90 dynamics and stability by client recruiter cochaperones: protein structure network modeling. Blacklock K, Verkhivker GM. PLoS One. 2014 Jan 20;9(1):e86547. doi: 10.1371/journal.pone.0086547. eCollection 2014. PMID: 24466147
Structure-functional prediction and analysis of cancer mutation effects in protein kinases. Dixit A, Verkhivker GM. Comput Math Methods Med. 2014;2014:653487. doi: 10.1155/2014/653487. Epub 2014 Apr 8. PMID: 24817905
Computational modeling of allosteric regulation in the hsp90 chaperones: a statistical ensemble analysis of protein structure networks and allosteric communications. Blacklock K, Verkhivker GM. PLoS Comput Biol. 2014 Jun 12;10(6):e1003679. doi: 10.1371/journal.pcbi.1003679. eCollection 2014 Jun. PMID: 24922508
Structure-Based Network Analysis of Activation Mechanisms in the ErbB Family of Receptor Tyrosine Kinases: The Regulatory Spine Residues Are Global Mediators of Structural Stability and Allosteric Interactions. James, K., Verkhivker GM. PLoS One. 2014, in press
Molecular Dynamics Simulations and Protein Structure Network Modeling of Abl and c-Src Tyrosine Kinases and Complexes with Inhibitors : Capturing Structural Stability, Selectivity and Drug Resistance Effects via Cooperative Interaction Networks. K. Blacklock, K. James, G.Stetz, G. Verkhivker. Plos Comput. Biol
Computational modeling of Hsp90 molecular chaperone structure, dynamics and function: a synergistic perspective from biophysical simulations and systems biology analysis. N. Lawless, E. Berrigan, K. Blacklock, G. Verkhivker.Molecular Systems Biology , 2014, submitted
Computational Studies of Allosteric Regulation in the Hsp90 Molecular Chaperone: From Functional Dynamics and Protein Structure Networks to Allosteric Communications and Targeted Anti-Cancer Modulators. G. Verkhivker Israel Journal of Chemistry, 2014,special volume on "Computational Chemistry of Biomolecules" published online: 19 FEB 2014, DOI: 10.1002/ijch.201300143.
Design, synthesis and evaluation of dasatinib-derived protein-tyrosine kinase inhibitors. A. Brown, R. Tiwari, A. Nasrolani Shirazi, J. Bolton, K. Parang, G. Sun, G. Verkhivker.J. Med. Chem. 2014, submitted
Differential modulation of functional dynamics and allosteric interactions in the Hsp90-cochaperone complexes with p23 and Aha1: a computational study. Blacklock K, Verkhivker GM. PLoS One. 2013 Aug 19;8(8):e71936. doi: 10.1371/journal.pone.0071936. eCollection 2013.
Experimentally guided structural modeling and dynamics analysis of Hsp90-p53 interactions: allosteric regulation of the Hsp90 chaperone by a client protein. Blacklock K, Verkhivker GM. J Chem Inf Model. 2013 Nov 25;53(11):2962-78. doi: 10.1021/ci400434g. Epub 2013 Nov 12. PMID: 24191708
Structural bioinformatics and protein docking analysis of the molecular chaperone-kinase interactions: towards allosteric inhibition of protein kinases by targeting the hsp90-cdc37 chaperone machinery. Lawless N, Blacklock K, Berrigan E, Verkhivker G. Pharmaceuticals (Basel). 2013 Nov 11;6(11):1407-28. doi: 10.3390/ph6111407. PMID: 24287464